Semiconductors
Compare Stocks
5 / 10Stock Comparison
INTT vs AEHR vs ACMR vs NVEC vs COHU
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
INTT vs AEHR vs ACMR vs NVEC vs COHU — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $208M | $2.79B | $3.92B | $429M | $2.23B |
| Revenue (TTM) | $121M | $49M | $901M | $26M | $481M |
| Net Income (TTM) | $591K | $-11M | $94M | $15M | $-56M |
| Gross Margin | 44.0% | 30.2% | 44.4% | 78.7% | 25.7% |
| Operating Margin | 0.7% | -27.8% | 12.1% | 60.5% | -10.6% |
| Forward P/E | 39.9x | — | 29.7x | 18.9x | 89.2x |
| Total Debt | $16M | $11M | $303M | $740K | $359M |
| Cash & Equiv. | $14M | $25M | $766M | $2M | $227M |
INTT vs AEHR vs ACMR vs NVEC vs COHU — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| inTEST Corporation (INTT) | 100 | 522.3 | +422.3% |
| Aehr Test Systems (AEHR) | 100 | 5530.9 | +5430.9% |
| ACM Research, Inc. (ACMR) | 100 | 297.0 | +197.0% |
| NVE Corporation (NVEC) | 100 | 146.4 | +46.4% |
| Cohu, Inc. (COHU) | 100 | 315.3 | +215.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INTT vs AEHR vs ACMR vs NVEC vs COHU
Each card shows where this stock fits in a portfolio — not just who wins on paper.
INTT ranks third and is worth considering specifically for stability.
- Beta 1.19 vs AEHR's 4.77
AEHR is the clearest fit if your priority is long-term compounding.
- 70.3% 10Y total return vs ACMR's 30.7%
- +9.9% vs NVEC's +52.6%
ACMR is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- PEG 0.84 vs NVEC's 3.54
- 15.2% revenue growth vs AEHR's -20.2%
- 0.2% yield, 3-year raise streak, vs NVEC's 4.5%, (3 stocks pay no dividend)
NVEC carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 1.58, yield 4.5%
- Lower volatility, beta 1.58, Low D/E 1.3%, current ratio 28.21x
- Beta 1.58, yield 4.5%, current ratio 28.21x
- Lower P/E (18.9x vs 89.2x)
Among these 5 stocks, COHU doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs AEHR's -20.2% | |
| Value | Lower P/E (18.9x vs 89.2x) | |
| Quality / Margins | 57.7% margin vs AEHR's -22.7% | |
| Stability / Safety | Beta 1.19 vs AEHR's 4.77 | |
| Dividends | 0.2% yield, 3-year raise streak, vs NVEC's 4.5%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +9.9% vs NVEC's +52.6% | |
| Efficiency (ROA) | 24.8% ROA vs AEHR's -7.5%, ROIC 21.2% vs -3.0% |
INTT vs AEHR vs ACMR vs NVEC vs COHU — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
INTT vs AEHR vs ACMR vs NVEC vs COHU — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NVEC leads in 3 of 6 categories
AEHR leads 1 • INTT leads 0 • ACMR leads 0 • COHU leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NVEC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACMR is the larger business by revenue, generating $901M annually — 34.2x NVEC's $26M. NVEC is the more profitable business, keeping 57.7% of every revenue dollar as net income compared to AEHR's -22.7%. On growth, COHU holds the edge at +29.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $121M | $49M | $901M | $26M | $481M |
| EBITDAEarnings before interest/tax | $6M | -$10M | $126M | $16M | -$11M |
| Net IncomeAfter-tax profit | $591,000 | -$11M | $94M | $15M | -$56M |
| Free Cash FlowCash after capex | -$3M | -$14M | -$69M | $14M | $32M |
| Gross MarginGross profit ÷ Revenue | +44.0% | +30.2% | +44.4% | +78.7% | +25.7% |
| Operating MarginEBIT ÷ Revenue | +0.7% | -27.8% | +12.1% | +60.5% | -10.6% |
| Net MarginNet income ÷ Revenue | +0.5% | -22.7% | +10.4% | +57.7% | -11.5% |
| FCF MarginFCF ÷ Revenue | -2.5% | -28.1% | -7.6% | +54.9% | +6.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.2% | -26.5% | +9.4% | +5.3% | +29.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +133.4% | -2.2% | -76.1% | +27.5% | +60.6% |
Valuation Metrics
NVEC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 28.2x trailing earnings, NVEC trades at a 35% valuation discount to ACMR's 43.2x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs NVEC's 5.28x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $208M | $2.8B | $3.9B | $429M | $2.2B |
| Enterprise ValueMkt cap + debt − cash | $209M | $2.8B | $3.5B | $428M | $2.4B |
| Trailing P/EPrice ÷ TTM EPS | -79.10x | -702.00x | 43.21x | 28.21x | -29.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 39.86x | — | 29.68x | 18.93x | 89.21x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.22x | 5.28x | — |
| EV / EBITDAEnterprise value multiple | 68.02x | — | 27.49x | 26.86x | — |
| Price / SalesMarket cap ÷ Revenue | 1.82x | 47.39x | 4.35x | 16.27x | 4.93x |
| Price / BookPrice ÷ Book value/share | 1.96x | 21.97x | 2.06x | 7.36x | 2.82x |
| Price / FCFMarket cap ÷ FCF | 36.52x | — | — | 29.62x | 207.83x |
Profitability & Efficiency
NVEC leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NVEC delivers a 25.6% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $-8 for AEHR. NVEC carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to COHU's 0.46x. On the Piotroski fundamental quality scale (0–9), NVEC scores 6/9 vs AEHR's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.6% | -8.5% | +6.1% | +25.6% | -6.8% |
| ROA (TTM)Return on assets | +0.4% | -7.5% | +3.9% | +24.8% | -4.9% |
| ROICReturn on invested capital | -2.6% | -3.0% | +7.0% | +21.2% | -5.7% |
| ROCEReturn on capital employed | -3.2% | -3.2% | +6.6% | +26.0% | -5.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 1 | 2 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.15x | 0.09x | 0.16x | 0.01x | 0.46x |
| Net DebtTotal debt minus cash | $1M | -$14M | -$463M | -$973,617 | $132M |
| Cash & Equiv.Liquid assets | $14M | $25M | $766M | $2M | $227M |
| Total DebtShort + long-term debt | $16M | $11M | $303M | $740,423 | $359M |
| Interest CoverageEBIT ÷ Interest expense | 2.17x | — | 20.44x | — | -168.82x |
Total Returns (Dividends Reinvested)
AEHR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEHR five years ago would be worth $398,515 today (with dividends reinvested), compared to $12,218 for COHU. Over the past 12 months, AEHR leads with a +991.6% total return vs NVEC's +52.6%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs INTT's -8.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +120.3% | +311.8% | +31.9% | +45.8% | +92.9% |
| 1-Year ReturnPast 12 months | +159.9% | +991.6% | +195.6% | +52.6% | +199.7% |
| 3-Year ReturnCumulative with dividends | -22.1% | +242.3% | +487.9% | +13.0% | +40.7% |
| 5-Year ReturnCumulative with dividends | +29.8% | +3885.1% | +133.4% | +38.6% | +22.2% |
| 10-Year ReturnCumulative with dividends | +327.0% | +7029.7% | +3065.8% | +124.0% | +330.2% |
| CAGR (3Y)Annualised 3-year return | -8.0% | +50.7% | +80.5% | +4.2% | +12.1% |
Risk & Volatility
Evenly matched — INTT and NVEC each lead in 1 of 2 comparable metrics.
Risk & Volatility
INTT is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than AEHR's 4.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVEC currently trades 98.4% from its 52-week high vs ACMR's 82.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.19x | 4.77x | 3.24x | 1.58x | 2.13x |
| 52-Week HighHighest price in past year | $19.75 | $102.48 | $71.65 | $90.00 | $50.68 |
| 52-Week LowLowest price in past year | $5.58 | $8.06 | $19.26 | $57.21 | $15.34 |
| % of 52W HighCurrent price vs 52-week peak | +84.1% | +89.1% | +82.6% | +98.4% | +93.7% |
| RSI (14)Momentum oscillator 0–100 | 55.5 | 67.6 | 60.7 | 63.8 | 75.5 |
| Avg Volume (50D)Average daily shares traded | 251K | 3.0M | 1.2M | 53K | 953K |
Analyst Outlook
Evenly matched — ACMR and NVEC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: INTT as "Buy", AEHR as "Hold", ACMR as "Buy", COHU as "Buy". Consensus price targets imply 4.8% upside for COHU (target: $50) vs -32.4% for ACMR (target: $40). For income investors, NVEC offers the higher dividend yield at 4.51% vs ACMR's 0.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | — | Buy |
| Price TargetConsensus 12-month target | $11.33 | $62.00 | $40.00 | — | $49.75 |
| # AnalystsCovering analysts | 5 | 3 | 10 | — | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.2% | +4.5% | — |
| Dividend StreakConsecutive years of raises | 0 | — | 3 | 2 | 0 |
| Dividend / ShareAnnual DPS | — | — | $0.11 | $4.00 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +0.0% | +0.2% | 0.0% | +0.3% |
NVEC leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). AEHR leads in 1 (Total Returns). 2 tied.
INTT vs AEHR vs ACMR vs NVEC vs COHU: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is INTT or AEHR or ACMR or NVEC or COHU a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -12. 9% for inTEST Corporation (INTT). NVE Corporation (NVEC) offers the better valuation at 28. 2x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate inTEST Corporation (INTT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — INTT or AEHR or ACMR or NVEC or COHU?
On trailing P/E, NVE Corporation (NVEC) is the cheapest at 28.
2x versus ACM Research, Inc. at 43. 2x. On forward P/E, NVE Corporation is actually cheaper at 18. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus NVE Corporation's 3. 54x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — INTT or AEHR or ACMR or NVEC or COHU?
Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +38.
9%, compared to +22. 2% for Cohu, Inc. (COHU). Over 10 years, the gap is even starker: AEHR returned +70. 3% versus NVEC's +124. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — INTT or AEHR or ACMR or NVEC or COHU?
By beta (market sensitivity over 5 years), inTEST Corporation (INTT) is the lower-risk stock at 1.
19β versus Aehr Test Systems's 4. 77β — meaning AEHR is approximately 300% more volatile than INTT relative to the S&P 500. On balance sheet safety, NVE Corporation (NVEC) carries a lower debt/equity ratio of 1% versus 46% for Cohu, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — INTT or AEHR or ACMR or NVEC or COHU?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -12. 9% for inTEST Corporation (INTT). On earnings-per-share growth, the picture is similar: NVE Corporation grew EPS 1. 0% year-over-year, compared to -187. 5% for inTEST Corporation. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — INTT or AEHR or ACMR or NVEC or COHU?
NVE Corporation (NVEC) is the more profitable company, earning 57.
7% net margin versus -16. 4% for Cohu, Inc. — meaning it keeps 57. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVEC leads at 60. 5% versus -13. 3% for COHU. At the gross margin level — before operating expenses — NVEC leads at 78. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is INTT or AEHR or ACMR or NVEC or COHU more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus NVE Corporation's 3. 54x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NVE Corporation (NVEC) trades at 18. 9x forward P/E versus 89. 2x for Cohu, Inc. — 70. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COHU: 4. 8% to $49. 75.
08Which pays a better dividend — INTT or AEHR or ACMR or NVEC or COHU?
In this comparison, NVEC (4.
5% yield), ACMR (0. 2% yield) pay a dividend. INTT, AEHR, COHU do not pay a meaningful dividend and should not be held primarily for income.
09Is INTT or AEHR or ACMR or NVEC or COHU better for a retirement portfolio?
For long-horizon retirement investors, NVE Corporation (NVEC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4.
5% yield, +124. 0% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NVEC: +124. 0%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between INTT and AEHR and ACMR and NVEC and COHU?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: INTT is a small-cap quality compounder stock; AEHR is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; NVEC is a small-cap income-oriented stock; COHU is a small-cap quality compounder stock. NVEC pays a dividend while INTT, AEHR, ACMR, COHU do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.